Creating a data platform to enhance biomedical research in Africa
Official title: eLwazi Open Science Data Platform for Africa
Funded at University of Cape Town · NIH-10928252 · Data updated 2026-11-12
This study is creating a helpful online platform that gives researchers in Africa access to important tools and training for analyzing health data, so they can work together and make new discoveries that improve health in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cape Town NIH-funded |
| Lab location | 1 site (Rondebosch, South Africa) |
| Project start | September 20, 2021 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,722,582 |
| NIH project number | 5U2CEB032224-04 |
| Project ID | NIH-10928252 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include researchers and healthcare professionals in Africa who are involved in biomedical research and data analysis.
✕Less likely to help
Patients who are not engaged in research or do not have access to the necessary technology may not benefit from this research.
What this research studies
This research aims to develop the eLwazi Open Science Data Platform, which will provide access to essential data science tools and resources for biomedical research in Africa. The platform will be designed to meet the specific needs of users in low and middle-income countries, enabling them to analyze complex biomedical datasets effectively. Participants will benefit from training programs and support to enhance their skills in data science, allowing them to contribute to health discoveries. The platform will facilitate data retrieval, analysis, and visualization, fostering collaboration among researchers.
Why it matters
Potential benefit: If successful, this research could significantly enhance the capacity for biomedical discoveries in Africa, leading to improved health outcomes.
How similar studies have gone: Similar initiatives have shown promise in enhancing research capabilities in other regions, indicating potential success for this novel approach.
Where this research is happening
-
University of Cape Town
Rondebosch, South Africa Active
Researchers
- Principal investigator: Mulder, Nicola — University of Cape Town
- Study coordinator: Mulder, Nicola
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.